Consistent with our in vitro findings, we observed that low ALK4 expression strongly correlated with active TGF-β signaling, whereas high ALK4 expression inversely correlated with TGF-β signaling in breast and pancreatic cancer specimens (Fig. 4e). The gene discussed is ACVR1B; the disease is familial pancreatic carcinoma.